共 50 条
[24]
EML4-ALK Rearrangement as a Mechanism of Resistance to Osimertinib in Metastatic Lung Adenocarcinoma: A Case Report
[J].
JTO CLINICAL AND RESEARCH REPORTS,
2021, 2 (06)
[26]
Codrug Approach for the Potential Treatment of EML4-ALK Positive Lung Cancer
[J].
ACS MEDICINAL CHEMISTRY LETTERS,
2020, 11 (03)
:316-321